Amalgamated Research

Executive Summary

Amalgamated Research (ARi) is a US-based process R&D company specializing in high-efficiency industrial separation, mixing, and fluid distribution, leveraging its patented fractal technology to reduce energy consumption and improve process efficiency. Founded in 1990 and headquartered in Twin Falls, Idaho, ARi designs and installs turnkey purification systems such as simulated moving bed (SMB) chromatography and ion exchange for diverse industries, including drug delivery. Its fractal-based innovations offer significant advantages in scalability and performance, positioning the company as a niche technology provider in the industrial separation market. Despite a lack of recent financial disclosures, ARi's long-standing presence and specialized expertise suggest a stable but non-public growth trajectory. The company's focus on drug delivery applications aligns with broader industry trends toward continuous manufacturing and process intensification, offering potential for strategic partnerships or technology licensing deals.

Upcoming Catalysts (preview)

• TBDNew drug delivery partnership or licensing agreement leveraging fractal technology40% success
• TBDMilestone in a major SMB chromatography installation for a pharmaceutical client55% success
• TBDPublication of a case study demonstrating significant energy savings in an FDA-regulated process50% success